September 10, 2025Diseases of the Esophagus

Multidisciplinary Treatment Strategy for Clinical Stage Iv Esophageal Cancer Including Cf + Ici Therapy and Conversion Surgery

View Full Paper

Ask AI

Bookmark

Combination therapy with immune check inhibitors showed a 1-year survival rate of 72.3% in non-cT4/cM1b patients.
Among 56 patients, conversion surgery was conducted in 14.3%, reflecting its potential role in treatment plans.
Multidisciplinary treatment strategies, including chemoradiation, may enhance long-term outcomes in clinical stage IVA esophageal cancer.
The study highlights the need for further evaluation in stage IVB, where systemic disease treatment shows limited efficacy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis indicates improved survival rates with ICI therapy and conversion surgery in esophageal cancer patients, suggesting a promising treatment approach.

Cite This Study

Yutaka Miyawaki (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478b7a6 https://doi.org/10.1093/dote/doaf061.350

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis indicates improved survival rates with ICI therapy and conversion surgery in esophageal cancer patients, suggesting a promising treatment approach.

Multidisciplinary Treatment Strategy for Clinical Stage Iv Esophageal Cancer Including Cf + Ici Therapy and Conversion Surgery

Key Points

Discussion

Implication

Cite This Study

Multidisciplinary Treatment Strategy for Clinical Stage Iv Esophageal Cancer Including Cf + Ici Therapy and Conversion Surgery

Key Points

Discussion

Implication

Cite This Study